The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model

被引:45
作者
Fang, JB [1 ]
Wang, GY [1 ]
Yang, Q [1 ]
Song, JN [1 ]
Wang, Y [1 ]
Wang, L [1 ]
机构
[1] NE Normal Univ, Sch Life Sci, Changchun 130024, Peoples R China
基金
中国国家自然科学基金;
关键词
tumor specific antigen; anti-tumor immunity; bacteriophage display;
D O I
10.1016/j.vaccine.2005.05.024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The tumor specific antigen epitope melanoma antigen A1(161-169) (MAGE-A1(161-169)) was displayed on the major protein (pVIII) of the filamentous bacteriophage (fd). The immune responses of the phage display particles expressing MAGE-A1161-169 in mice were studied. Using phage display particles as vaccine was effective in affording protection from tumor growth, inducing growth control of established tumors and prolonging survival of tumor-bearing mice. The hybrid phage particles elicited MAGE-A1(161-169) specific CTL responses, NK activity and DTH. Our results showed that the phage display particles might be a new vaccine candidate for tumor-associated antigen epitope in cancer immunotherapy. (c) 2005 Published by Elsevier Ltd.
引用
收藏
页码:4860 / 4866
页数:7
相关论文
共 32 条
  • [1] ACHIM AJ, 2000, INT J CANCER, V85, P460
  • [2] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [3] BAGE - A NEW GENE ENCODING AN ANTIGEN RECOGNIZED ON HUMAN MELANOMAS BY CYTOLYTIC T-LYMPHOCYTES
    BOEL, P
    WILDMANN, C
    SENSI, ML
    BRASSEUR, R
    RENAULD, JC
    COULIE, P
    BOON, T
    VANDERBRUGGEN, P
    [J]. IMMUNITY, 1995, 2 (02) : 167 - 175
  • [4] Clay TM, 2001, CLIN CANCER RES, V7, P1127
  • [5] Cohen PA, 2000, CRIT REV IMMUNOL, V20, P17
  • [6] DANILA V, 2001, CANCER RES, V61, P509
  • [7] Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages
    De Berardinis, P
    D'Apice, L
    Prisco, A
    Ombra, MN
    Barba, P
    Del Pozzo, G
    Petukhov, S
    Malik, P
    Perham, RN
    Guardiola, J
    [J]. VACCINE, 1999, 17 (11-12) : 1434 - 1441
  • [8] DREW MP, 1998, CURR OPIN IMMUNOL, V10, P588
  • [9] FULVIA DMV, 1994, J MOL BIOL, V243, P167
  • [10] Immune responses to tumour antigens:: implications for antigen specific immunotherapy of cancer
    Jäger, D
    Jäger, E
    Knuth, A
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (09) : 669 - 674